Korro Bio, Inc.
Korro Bio, Inc. (KKR) — Form SCHEDULE 13G: Ownership over 5% (passive)
AI-generated summary
Capital International Investors filed a Schedule 13G reporting a passive stake of 45,547,880 shares of Common Stock in Korro Bio, Inc. This holding represents 5.0% of the company's shares. The filing was submitted on November 13, 2026.
Key facts
- Document
- —
More KKR filings
- 10-Q
Filed Nov 9, 2026
- 8-K
Filed Nov 9, 2026
- 8-K
Filed Nov 4, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Oct 26, 2026
- 3
Filed Oct 26, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.